Multicenter, dual fractionation scheme, single core lab comparison of rectal volume dose reduction following injection of two biodegradable perirectal spacers
Authors:
Open Access
- 28 June 2023
- journal article
- research article
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 24 (10) , e14086
Abstract
Purpose: A multicenter, double‐arm, central core lab, retrospective study was performed to compare the rectal dosimetry of patients implanted with two injectable, biodegradable perirectal spacers, in conventional fractionation (CF), as well as ultrahypofractionation (UH) treatment plans.Methods and materials: Fifty‐nine patients were enrolled into the study in five centers: two centers in Europe, which implanted a biodegradable balloon spacer in a total of 24 subjects and three centers in the US, which implanted the SpaceOAR in 35 subjects. Anonymized CTs (pre and post‐implantation) were reviewed by the central core lab. For VMAT CF plans rectal V50, V60, V70, and V80 were calculated. For UH plans, a corresponding rectal V22.6, V27.1, V31.37, and V36.25 were established representing 62.5%, 75%, 87.5%, and 100% of the 36.25 Gy prescribed dose.Results: For CF VMAT, a comparison between the balloon spacer and the SpaceOAR revealed a significant difference of 33.4% decrease in mean rectal V50 (71.9% vs. 38.5%, p < 0.001), 27.7% in mean rectal V60 (79.6% vs. 51.9%, p < 0.001), 17.1% difference in mean rectal V70 (84.1% vs. 67.0%, p = 0.001), and a significant difference of 3.0% (p = 0.019) in mean rectal V80 (87.2% vs. 84.2%). With UH analysis, the mean rectal dose reduction for the balloon spacer compared to the SpaceOAR was 79.2% and 53.3% for V27.1 (p < 0.001), 84.1% and 68.1% for V31.71 (p = 0.001), and 89.7% and 84.8% for V36.25 (p = 0.012), respectively.Conclusion: Rectal dosimetry is more favorable for treatment with the balloon spacer compared with SpaceOAR. Further research, particularly in the context of a prospective randomized clinical trial design, is needed to assess the acute and late toxicity experience as well as physician satisfaction with achieving symmetrical implantation, and ease of use in light of increasing clinical use.Keywords
This publication has 18 references indexed in Scilit:
- SpaceOAR Hydrogel in Dose-escalated Prostate Cancer Radiotherapy: Rectal Dosimetry and Late ToxicityClinical Oncology, 2016
- Prostate motion during radiotherapy of prostate cancer patients with and without application of a hydrogel spacer: a comparative studyRadiation Oncology, 2015
- Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2015
- Application of a hydrogel spacer for postoperative salvage radiotherapy of prostate cancerStrahlentherapie und Onkologie, 2014
- Feasibility of and rectal dosimetry improvement with the use of SpaceOAR® hydrogel for dose‐escalated prostate cancer radiotherapyJournal of Medical Imaging and Radiation Oncology, 2014
- A Multi-institutional Clinical Trial of Rectal Dose Reduction via Injected Polyethylene-Glycol Hydrogel During Intensity Modulated Radiation Therapy for Prostate Cancer: Analysis of Dosimetric OutcomesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Application of an interstitial and biodegradable balloon system for prostate-rectum separation during prostate cancer radiotherapy: a prospective multi-center studyRadiation Oncology, 2013
- Low rectal toxicity after dose escalated IMRT treatment of prostate cancer using an absorbable hydrogel for increasing and maintaining space between the rectum and prostate: Results of a multi-institutional phase II trialRadiotherapy and Oncology, 2013
- Interstitial biodegradable balloon for reduced rectal dose during prostate radiotherapy: Results of a virtual planning investigation based on the pre- and post-implant imaging data of an international multicenter studyRadiotherapy and Oncology, 2013
- Human Collagen Injections to Reduce Rectal Dose During RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012